DOI: http://dx.doi.org/10.18203/2319-2003.ijbcp20161465

A comparison study of the clinical efficacy and safety of topical adapalene gel (0.1%) and tretinoin cream (0.025%) in the treatment of acne vulgaris

Usha Naraindas Khemani, Uday S. Khopkar, Chitra S. Nayak

Abstract


Background: Adapalene a synthetic retinoid analogue, is an addition to the arsenal of topical retinoids developed for the topical treatment of acne vulgaris. The study was designed to compare the clinical efficacy and safety of topical adapalene gel 0.1% and tretinoin cream 0.025% in the treatment of acne vulgaris.

Methods: A total of 80 patients with grade I-III acne vulgaris seen in the out-patient department of a tertiary care center were randomized to 8 weeks of daily treatment with either adapalene gel 0.1% or tretinoin gel 0.025%. Counts of total lesions, inflammatory lesions and non-inflammatory lesions were made at baseline and again at treatment weeks 2, 4, 6 and 8. Global assessment ratings, based on percent lesion reduction from baseline were also made. Side-effects like erythema, burning, pruritus, scaling and dryness were rated on a 0-3 severity scale.

Results: Out of 80 patients there were 8 dropouts in the study; the 72 patients who completed the study were evaluated for efficacy and safety. Both adapalene and tretinoin produce dramatic reductions in total, inflammatory and non-inflammatory lesion counts, on an average. Cutaneous side-effects were limited to a mild retinoid dermatitis occurring in both treatment groups however patients treated with adapalene gel tolerated this therapy significantly better than those treated with tretinoin cream.

Conclusions: Adapalene gel 0.1% offers comparable efficacy to tretinoin cream 0.025 % cream, but is less irritating. Adapalene gel 0.1% is a safe and effective topical agent in the treatment of mild to moderate acne vulgaris in Indian patients.


Keywords


Adapalene, Tretinoin, Acne vulgaris, Treatment

Full Text:

PDF

References


Cunliffe WJ, Cotterill JA. The acnes: clinical features, pathogenesis and treatment; W.B. Saunders Company Ltd. London;1975:1-6.

Jonathan W, Joel S. Adapalene gel for the treatment of acne vulgaris. 1998;39(2):50-4.

Braham S, Serge M. Pharmacology and chemistry of adapalene. J Am Acad Dermatol. 1997;36(6):96-103.

Burke BM, Cunliffe WJ. The assessment of acne vulgaris: the leeds technique. Br J Dermatol. 1984;3:83-92.

Pillsbury DM: A manual of dermatology. Philadelphia, WB Saunders Co;1971:173.

Rook A: Acne vulgaris in text book of dermatology (ed) Rook A, Wilkinson DS, Ebling F JG, Blackwell scientific, Oxford, 6th edition. 1998;1940-82.

Burton JL, Cunliffe WJ, Stafford, Shuster S. The prevalence of acne vulgaris in adolescence. Br J Dermatol. 1971;85:119-26.

Pandey SS. Epidemiology of acne vulgaris. Ind J Dermatol Venereol Leprol. 1978;45:109.

Shalita A, Weiss JS, Chalker DK, Ellis CN, Greenspan A, Katz HI. A comparison of the efficacy and safety of the adapalene gel 0.1% and tretinoin gel 0.025% in the treatment of acnevulgaris: A multicenter trial. J Am Acad Dermatol. 1996;34:482-5.

Dunlap FE, Cunliffe WJ, Mills OH, Tuley MR. Adapalene 0.1% gel for the treatment of acne vulgaris: its superiority comprised to tretinoin 0.025% cream in skin tolerance and patient preference. Br J Dermatol. 1998;139(52):17-22.

Grosshans E, Marks R, Mascaro JM, Torras H, Meynadier J, Alirezai M. Evaluation of clinical efficacy and safety of adapalene 0.1% gel versus tretinoin 0.025% gel in the treatment of acne vulgaris, with particular reference to the onset of action and impact on quality of life: Br J Dermatol. 1998;139(52):26-33.

Cunliffe WJ, Poncet M, Loesche C, Verschoore M. A comparison of the efficacy and tolerability of adapalene 0.1% gel versus tertinoin 0.025% gel in patient with acne vulgaris - A meta-analysis of five randomized trials: Br J Dermatol. 1998;52:48-56.

Ellis CN, Millikan LE, Smith EB, Chalker DM, Swinyer LJ, Katz IH, et al. Comparison of adapalene 0.1% solution and tretinoin 0.025% gel in the topical treatment of acne vulgaris: Br Dermatol. 1998;139(52):41-7.

Toole JW, Lockhart L, Potrebka J, Bowman JP, Novack GD. Comparative irritancy study among retinoid creams and gels. J Cutan Med Surg. 1999;3:298-301.

Egan N, Loesche C, Baker M. Randomized, controlled, bilateral (split-face) comparison trial of the tolerability and patient preference of adapalene gel 0.1% and tretinoin microsphere gel 0.1% for the treatment of acne vulgaris. Cutis. 2001;68:20-4.

James JL, Alan RS, John EW. Current concepts in the treatment of acne vulgaris: highlights from a symposium held at a European academy of Dermatology and Venerology 2000 Annual Meeting, Geneva, Switzerland, October 12, 2000.

Alirezai M, Meynadier J, Jablonska S. Comparative study of the efficacy and tolerability of 0.1% and 0.3% adapalene gel and 0.025% tretinoin gel in the treatment of acne. Ann Dermatol Venerol. 1996;123:165-70.

Brogden RN, Goa K. Adapalene - review of its pharmacological properties and clinical potential in the management of mild to moderate acne. Drugs. 1997;53:511-9.

Hensby C, Vavey D, Bouclier M. The in vivo and in vitro anti-inflammatory activity of CD271: a new retinoid like modulator of cell differentiation. Agents Actions. 1990;29:56.